Early Feasibility Study of the Supira System in Patients Undergoing HRPCI
NCT06087575
Arterial Occlusive Diseases, Arteriosclerosis
Sacramento, California, United States
View Trial DetailsNCT Number: NCT02900456
Intra-aortic Balloon Pumps (IABP) have been used for roughly 50 years in Critical Care Units, Intensive Care Units, Cath labs as a way to improve systemic and coronary circulation in patients in cardiogenic shock (CS) or at high risk situation as mechanical complications stemming from myocardial infarction (MI), critical coronary stenosis, high-risk PCI, etc. Several papers recently questioned the relevance of this assistance device - namely the IABP-SHOCK II trial in CS and the CRISP-AMI trial in anterior MI without CS - resulting in the downgrading of the recommendation standards of the IABP by medical societies.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
CHU Angers, Angers, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year
Time frame: 1 year
IABP indications
Time frame: 1 year
IABP indications
Time frame: 1 year
IABP indications
Time frame: 1 year
IABP indications
Time frame: 1 year
Time frame: 1 year
Rennes University Hospital
Other
Acronym: CP-GARO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06087575
Arterial Occlusive Diseases, Arteriosclerosis
Sacramento, California, United States
View Trial DetailsNCT02270242
Cardiovascular Disease, Cardiovascular Diseases
New York, United States
View Trial DetailsNCT03848572
Cardiovascular Diseases, Hemorrhage
Rome, Italy
View Trial DetailsNCT07296744
Arterial Occlusive Diseases, Arteriosclerosis
Loma Linda, California, United States
View Trial Details